Technological advances in single-use or disposable bronchoscopy: an evaluation of the Innovative Ambu® aScope™ 5 in a quaternary referral bronchoscopy unit.

IF 1.9 3区 医学 Q3 RESPIRATORY SYSTEM Journal of thoracic disease Pub Date : 2025-01-24 Epub Date: 2025-01-22 DOI:10.21037/jtd-24-1538
Noreen Tangney, Emily O'Reilly, Mairead O'Donnell, Anne O'Mahony, Kevin Deasy, Hisham Ibrahim, Andre Pozza, Marcus Peter Kennedy
{"title":"Technological advances in single-use or disposable bronchoscopy: an evaluation of the Innovative Ambu<sup>®</sup> aScope™ 5 in a quaternary referral bronchoscopy unit.","authors":"Noreen Tangney, Emily O'Reilly, Mairead O'Donnell, Anne O'Mahony, Kevin Deasy, Hisham Ibrahim, Andre Pozza, Marcus Peter Kennedy","doi":"10.21037/jtd-24-1538","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Single-use flexible bronchoscopes (SUFBs) offer various advantages over reusable bronchoscopes (RBs) including portability and cost-effectiveness, and potentially reduced infection transmission. Our study aimed to review the performance of the Ambu<sup>®</sup> aScope™ 5 Broncho suite in Cork University Hospital.</p><p><strong>Methods: </strong>Following ethical approval, data was collected prospectively on procedures performed with the Ambu<sup>®</sup> aScope™ 5 in Cork University Hospital. Data included patient demographics, procedure details (location, indication, SUFB size, procedures, complications), and user satisfaction and demographics.</p><p><strong>Results: </strong>There were 98 procedures performed with the Ambu<sup>®</sup> aScope™ 5, all in the endoscopy suite. There were 42 female patients (42.9%) and 56 male (57.1%). Various sized models were used-2.7/1.2 (n=3), 4.2/2.2 (n=4), 5/2.2 (n=60), 5.6/2.8 (n=31). Infection was the most common indication while others included malignancy, haemoptysis, sarcoidosis, and asthma. The most commonly performed procedure was airway inspection (n=98), while bronchoalveolar lavage (BAL) (n=84), brushings (n=3), endobronchial biopsies (n=5), transbronchial needle aspiration (TBNA) (n=1), and argon plasma coagulation (APC) (n=1) were among others. The average user satisfaction rating (from one to five in ascending order of satisfaction) was 4.8 [5 (n=85), 4 (n=9), 3 (n=1), 2 (n=3), 1 (n=0)]. The most common reason for user dissatisfaction was related to suction (n=3). Conversion from single-use to RB was not required in any case. There were no bronchoscope-related patient complications.</p><p><strong>Conclusions: </strong>Within this cohort of patients, the Ambu<sup>®</sup> aScope™ 5 was both safe and versatile with a high level of user satisfaction.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"17 1","pages":"42-50"},"PeriodicalIF":1.9000,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11833555/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-1538","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Single-use flexible bronchoscopes (SUFBs) offer various advantages over reusable bronchoscopes (RBs) including portability and cost-effectiveness, and potentially reduced infection transmission. Our study aimed to review the performance of the Ambu® aScope™ 5 Broncho suite in Cork University Hospital.

Methods: Following ethical approval, data was collected prospectively on procedures performed with the Ambu® aScope™ 5 in Cork University Hospital. Data included patient demographics, procedure details (location, indication, SUFB size, procedures, complications), and user satisfaction and demographics.

Results: There were 98 procedures performed with the Ambu® aScope™ 5, all in the endoscopy suite. There were 42 female patients (42.9%) and 56 male (57.1%). Various sized models were used-2.7/1.2 (n=3), 4.2/2.2 (n=4), 5/2.2 (n=60), 5.6/2.8 (n=31). Infection was the most common indication while others included malignancy, haemoptysis, sarcoidosis, and asthma. The most commonly performed procedure was airway inspection (n=98), while bronchoalveolar lavage (BAL) (n=84), brushings (n=3), endobronchial biopsies (n=5), transbronchial needle aspiration (TBNA) (n=1), and argon plasma coagulation (APC) (n=1) were among others. The average user satisfaction rating (from one to five in ascending order of satisfaction) was 4.8 [5 (n=85), 4 (n=9), 3 (n=1), 2 (n=3), 1 (n=0)]. The most common reason for user dissatisfaction was related to suction (n=3). Conversion from single-use to RB was not required in any case. There were no bronchoscope-related patient complications.

Conclusions: Within this cohort of patients, the Ambu® aScope™ 5 was both safe and versatile with a high level of user satisfaction.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一次性或一次性支气管镜检查的技术进步:创新Ambu®aScope™5在四级转诊支气管镜检查单位的评估。
背景:一次性柔性支气管镜(sufb)与可重复使用的支气管镜(RBs)相比具有多种优势,包括便携性和成本效益,并可能减少感染传播。我们的研究旨在回顾科克大学医院Ambu®aScope™5 Broncho套件的性能。方法:经伦理批准后,前瞻性地收集科克大学医院使用Ambu®aScope™5进行手术的数据。数据包括患者人口统计、手术细节(位置、适应症、SUFB大小、手术、并发症)、用户满意度和人口统计。结果:使用Ambu®aScope™5完成了98例手术,全部在内窥镜套件中进行。女性42例(42.9%),男性56例(57.1%)。使用各种大小的模型,分别是:2.7/1.2 (n = 3), 4.2/2.2 (n = 4), 5/2.2 (n = 60), 5.6/2.8 (n = 31)。感染是最常见的适应症,其他包括恶性肿瘤、咯血、结节病和哮喘。最常见的检查方法是气道检查(n=98),支气管肺泡灌洗(n=84)、刷洗(n=3)、支气管内活检(n=5)、经支气管穿刺(TBNA) (n=1)和氩浆凝固(APC) (n=1)。用户平均满意度评分(从1到5的满意度升序)为4.8 [5 (n=85), 4 (n=9), 3 (n=1), 2 (n=3), 1 (n=0)]。用户不满意的最常见原因与吸力有关(n=3)。在任何情况下都不需要从一次性使用转换为RB。患者无支气管镜相关并发症。结论:在这组患者中,Ambu®aScope™5既安全又通用,用户满意度高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
期刊最新文献
First-line treatment strategies for BRAF-V600E mutated non-small cell lung cancer: lessons from real-world data and ongoing uncertainties. Flumonertinib after prior third-generation EGFR-tyrosine kinase inhibitor (TKI) therapy in patients with epidermal growth factor receptor-mutated non-small cell lung cancer after resistance to third-generation tyrosine kinase inhibitor treatment: a real-world study. Hemoglobin glycation index and mortality risk in severe community-acquired pneumonia: a retrospective study. Liposomal bupivacaine for postoperative analgesia after thoracoscopic surgery: a systematic review and meta-analysis. Isoforskolin inhibits LUBAC/GSDMD/IL-1β cascades in pulmonary fibrosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1